Virtual Medicinal Product (VMP)
-
Ganciclovir 0.15% eye gel
Name Details
Current Name
Ganciclovir 0.15% eye gel
|
Start Date
27-02-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Ocular
- Form
- Eye gel
- Ontology Form/Route
- gel.ophthalmic
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
S01AD09
BNF |
Current BNF
11030300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
11030300
|
Start Date
06-11-2009
|
End Date
03-04-2022
|
Previous BNF
11030300
|
Start Date
15-02-2005
|
End Date
10-10-2006
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41486411000001100 |
17-02-2023 |
|
408597001 |
15-08-2005 |
16-02-2023 |
3983311000001107 |
27-02-2003 |
14-08-2005 |
VMP Ingredients
VMP ingredients table
Ganciclovir |
Based on Ingredient Substance |
|
1.5 mg |
1 gram |
Name
Ganciclovir
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1.5
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Ganciclovir
-
VMP
(Current) Ganciclovir 0.15% eye gel
Virtual Medicinal Product Pack (VMPP) Information
5 gram |
1999 |
Part VIIIA Category C |